Results 81 to 90 of about 908,413 (222)
Artificial Intelligence and Machine Learning in the Context of Hemophilia: A Scope Review
ABSTRACT Introduction Advances in hemophilia treatment have improved life expectancy, yet challenges remain in disease management, predicting clinical complications, and optimizing healthcare resources. Artificial intelligence (AI) and machine learning (ML) have emerged as promising tools to support clinical decision‐making and personalized care ...
Tatyane Oliveira Rebouças +4 more
wiley +1 more source
Acquired hemophilia A: A case report
Acquired hemophilia A is a rare autoimmune disorder where autoantibodies are produced against factor VIII. Its reported incidence is as low as 1.20 to 1.48 cases per million per years.
Sarita Pradhan, Adya Kinkar Panda
doaj +1 more source
ABSTRACT Introduction There is limited qualitative published real‐world data on treatment patterns among people with severe haemophilia A (PwSHA), particularly those with unmet needs. Aim This qualitative study aimed to explore the impact of taking prophylactic extended half‐life factor VIII (EHL‐FVIII) or emicizumab on psychosocial and physical ...
Nana Kragh +7 more
wiley +1 more source
Hemophilia A - acquired during coronary artery bypass grafting [PDF]
We report a challenging case of a rare cause of post operative bleeding that occurred after the coronary artery by-pass graft procedure. We believe that acquired hemophilia A was the main culprit. Patient post CABG developed nonsurgical bleeding with new
Akintorin Abayomi +4 more
doaj
ABSTRACT The evolving haemophilia care landscape has evolved with personalised prophylaxis, new coagulation factor molecules, non‐replacement therapies, and gene therapy, leading to significantly reduced bleeding frequency and haemophilic arthropathy burden.
Hortensia De la Corte‐Rodriguez +16 more
wiley +1 more source
Acquired Hemophilia in a Patient with Rheumatoid Arthritis
Acquired hemophilia is a rare disease caused by an autoimmune reaction to coagulation factor VIII, The mortality rate of this disease is very high (8 22%). Clinical manifestations are different from congenital hemophilia.
���������
core
Acquired hemophilia of unknown etiology in an elderly man:Case report
Objective: Unknown ethiology Background: Acquired hemophilia is a rare but potentially dangerous bleeding disorder caused by autoantibodies against coagulation factors. It affects 1 to 1.5 per 1 million people each year.
Lim, Soo Min +4 more
core +1 more source
ABSTRACT Introduction Physical activity guidelines for children with inherited or acquired bleeding disorders are largely based on expert opinion rather than objective measures of injury exposure, making evidence‐based participation recommendations challenging.
Lauren Backstein +10 more
wiley +1 more source
Key Points The fVIII C1 domain contributes significantly to the immune response against fVIII in acquired and congenital hemophilia inhibitor patients. B-cell epitopes identified for monoclonal murine and human C1 inhibitors are recognized
Ernest T. Parker +10 more
core +1 more source
The author report a case involving a 60-year-old man with acquired hemophilia who presented with sudden-onset left abdominal pain and exhibited retroperitoneal hematoma and hemothorax.
Dong-Kyu Kim
doaj +1 more source

